Use of neuromonitoring during spinal cord stimulator surgery varies significantly across the US. In some regions, multimodality neuromonitoring is used routinely for all procedures. In other regions, it’s rarely used at all. With more than a decade of research on the utility of IONM for SCS placement, Dr. Falowski is interviewed by Dr. Vogel about the results of his research.

Richard Vogel, PhD, DABNM- Neurological Monitoring Associates, LLC, Milwaukee, WI

Stephen M. Falowski, MD- St. Lukes University Health Network, Bethlehem, PA

Disclosures:

Falowski, Steven M.: Consulting: Abbott (F), Medtronic (E), Vertiflex (F), Vertoss (D); Stock Ownership: AGR (less than 1%), Celeri (less than 1%), Cornerloc (less than 1%), Neural Integrative Solutions (50%), Saluda (less than 1%), Spinethera (less than 1%), SPR (less than 1%), Stimgenics (less than 1%), Thermaquil (less than 1%).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President (2019-2020)); Other: NuVasive Clinical Services (Salary, employment ended May 2021); Stock Ownership: NuVasive (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+